EPISODE · Apr 7, 2026 · 27 MIN
Ozempic for Heart Disease — The New Research - The Heart Failure Connection
from Ozempic for Heart Disease — The New Research · host Inception Point AI
Julia Cartwright explores groundbreaking research showing semaglutide (Ozempic/Wegovy) reduces heart failure hospitalizations by 70% in HFpEF patients—a stubborn condition affecting millions with few treatment options. The episode examines clinical trial data revealing benefits beyond weight loss, including reduced inflammation and improved heart function, marking a potential paradigm shift in cardiovascular medicine. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
Embed this episode
NOW PLAYING
Ozempic for Heart Disease — The New Research - The Heart Failure Connection
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.